is retatrutide a triple agonist Eli Lilly and Company's agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Lilly's triple agonist delivers up
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13

























